Virus-induced transient bone marrow aplasia: Major role of interferon- α/β during acute infection with the noncytopathic lymphocytic choriomeningitis virus

Journal of Experimental Medicine

Volumn 185, Issue 3, 1997, Pages 517-530

  Binder, Daniel ^a,b   Fehr, Jörg ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; FAS ANTIGEN; GAMMA INTERFERON; PERFORIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE MARROW APLASIA; BONE MARROW SUPPRESSION; COLONY FORMING UNIT S; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HEMATOPOIETIC STEM CELL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PANCYTOPENIA; PRIORITY JOURNAL; VIRUS REPLICATION; VIRUS VIRULENCE;

ACUTE DISEASE; ANIMALS; BLOOD CELL COUNT; BONE MARROW; CYTOTOXICITY, IMMUNOLOGIC; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; INTERFERON-ALPHA; INTERFERON-BETA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; MICE; MICE, INBRED STRAINS; RECEPTORS, INTERFERON; VIRUS REPLICATION;

EID: 0031054640     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.3.517     Document Type: Article

References (65)

1. Rosenfeld, S., and N.S. Young. 1991. Viruses and bone marrow failure. Blood. Rev. 5:71-77.
2. Young, N.S., M. Yoshida, and W. Sugden. 1992. Viral pathogenesis of hematologix disorders. In Molecular Basis of Blood Diseases. G. Stamatoyanapoulos, A.S. Nienhuis, P. Leder, P. Majerus and H. Varmus, editors. WB Saunders Company, Philadelphia.
3. Apperley, J.F., C. Dowding, J. Hibbin, J. Buiter, E. Matutes, P.J. Sissons, M. Gordon, and J.M. Goldman. 1989. The effect of cytomegalovirus on hemopoiesis: in vitro evidence for selective infection of marrow stromal cells. Exp. Hematol. 17: 38-45.
4. Molina, J.-M., D.T. Scadden, M. Sakaguchi, B. Fuller, A. Woon, and J.E. Groopman. 1990. Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood. 76:2476-2482.
5. Shadduck, R.K., A. Winkelstein, Z. Ziegler, J. Lichter, M. Goldstein, M. Michaels, and B. Rabin. 1979. Aplastic anemia following infectious mononucleosis: possible immune etiology. Exp. Hematol. 7:264-271.
6. Liang, D.C., K.H. Lin, D.T. Lin, C.P. Yang, K.L. Hung, and K.S. Lin. 1990. Post-hepatitis aplastic anemia in children in Taiwan, a hepatitis prevalent area. Br. J. Haematol. 74:487-491.
7. Buchmeier, M.J., R.M. Welsh, F.J. Dutko, and M.B.A. Oldstone. 1980. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv. Immunol. 30: 275-331.
8. Oldstone, M.B.A. 1987. The arenaviruses - an introduction. Curr. Topics. Microbiol. Immun. 133:1-4.
9. Lehmann-Grube, F. 1971. Lymphocytic choriomeningitis virus. Monogr. Virol. 10:1-173.
10. Hotchin, J.E. 1971. Persistent and slow virus infections. Monogr. Virol. 3:1-211.
11. Hinmann, A.R., D.W. Fraser, R.G. Douglas, G.S. Bowen, A.L. Kraus, W.G. Winkler, and W.W. Rhodes. 1975. Outbreak of lymphocytic choriomeningitis virus infections in medical center personnel. Am. J. Epidemiol. 101:103-110.
12. Smadel, J.E., R.H. Green, R.M. Paltauf, and T.A. Gonzales. 1942. Lymphocytic choriomeningitis: two human fatalities following an unusual febrile illness. Proc. Soc. Exp. Biol., N. Y. 49:683-686.
13. Martinez Peralta, L.A., C.E. Coto, and M.G. Weissenbacher. 1993. The Tacaribe complex: the close relationship between a pathogenic (Junin) and a nonpathogenic (Tacaribe) arenavirus. In The Arenavindae. M.S. Salvato, editor. Plenum Press, New York.
14. Bro-Jørgensen, K. 1978. The interplay between lymphocytic choriomeningitis virus, immune function, and hemopoiesis in mice. Adv. Virus. Res. 22:327-369.
15. Broomhall, K.S., M. Morin, D.C. Pevear, and C.J. Pfau. 1987. Severe and transient pancytopenia associated with a chronic arenavirus infection. J. Exp. Pathol. 3:259-269.
16. Silberman, S.L., R.P. Jacobs, and G.A. Cole. 1978. Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus. Infect. Immun. 19:533-539.
17. Thomsen, A.R., P. Pisa, K. Bro-Jørgensen, and R. Kiessling. 1986. Mechanisms of lymphocytic choriomeningitis virus-induced hemopoietic dysfunction. J. Virol. 59:428-133.
18. Zinkernagel, R.M., and R.M. Welsh. 1976. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J. Immunol. 117:1495-1502.
19. Hotchin, J. 1962. The biology of lymphocytic choriomeningitis infection: Virus induced immune disease. Cold Spring Harbor Symp. Quant. Biol. 27:479-499.
20. Moskophidis, D., M. Battegay, M.A. Bruendler, E. Laine, I. Gresser, and R.M. Zinkernagel. 1994. Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J. Virol. 68:1951-1955.
21. Müller, U., U. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science (Wash. DC). 264:1918-1921.
22. Biron, C.A., and R.M. Welsh. 1982. Blastogenesis of natural killer cells during viral infection in vivo. J. Immunol. 129: 2788-2795.
23. Welsh, R.M. 1978. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J. Exp. Med. 148: 163-181.
24. Kägi, D., B. Ledermann, K. Bürki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.). 369:31-37.
25. Karupiah, G., R.V. Blanden, and I.A. Ramshaw. 1990. Interferon-γ is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J. Exp. Med. 172:1495-1503.
26. Paya, C.V., R.A. Kenmotsu, R.A. Schoon, and P.J. Leibson. 1988. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 141:1989-1995.
27. Murphy, M., R. Loudon, M. Kobayashi, and G. Trinchieri. 1986. Gamma-interferon and lymphotoxin released by activated T cells synergize to inhibit granulocyte/monocyte colony formation. J. Exp. Med. 164:263-279.
28. van den Broek, M.F., D. Kägi, R.M. Zinkernagel, and H. Hengartner. 1995. Perform dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25:3514-3516.
29. Hisashi, A., A. Noriko, and S. Takashi. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1235-1238.
30. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-gamma receptor. Science (Wash. DC). 259:1742-1745.
31. Fung-Leung, W.P., T.M. Kündig, R.M. Zinkernagel, and T.W. Mak. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425-1429.
32. Rahemtulla, A., W.P. Fung-Leung, M.W. Schilham, T.M. Kündig, S.R. Sambhara, A. Narendran, A. Arabian, A. Wakeham, C.J. Paige, R.M. Zinkernagel et al. 1991. Normal development and function of CD8+ cells but a markedly decreased helper cell activity in mice lacking CD4. Nature (Lond.). 353:180-184.
33. Pfau, C.J., J.K. Valenti, D.C. Pevear, and K.D. Hunt. 1982. Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections. J. Exp. Med. 156:79-89.
34. Dutko, F.J., and M.B.A. Oldstone. 1983. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J. Gen. Virol. 64:1689-1698.
35. Battegay, M., S. Cooper, A. Althage, J. Baenziger, H. Hengartner, and R.M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods. 33:191-198.
36. Bro-Jørgensen, K., and M. Volkert. 1972. Haemopoietic defects in mice infected with lymphocytic choriomeningitis virus. 2. The viral effect upon the function of colony forming stem cells. Acta. Pathol. Microbiol. Scand. (B). 80:853-862.
37. Broudy, V.C., L.L. Nancy, and K. Kaushansky. 1995. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood. 85:1719-1726.
38. Tanaka, T., F. Kitamura, Y. Nagasaka, K. Kuida, H. Suwa, and M. Miyasaka. 1993. Selective long-term elimination of natural killer cells in vivo by an anti-interleukin 2 receptor β chain monoclonal antibody in mice. J. Exp. Med. 178:1103-1107.
39. Riviere, Y., I. Gresser, J.C. Guillon, MT. Bandu, P. Ronco, L. Morel-Maroger, and P. Verroust. 1980. Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J. Exp. Med. 152:633-640.
40. Leist, T.P., M. Aguet, M. Hassig, D.C. Pevear, C.J. Pfau, and R.M. Zinkemagel. 1987. Lack of correlation between serum titres of interferon alpha, beta, natural killer cell activity and clinical susceptibility in mice infected with two isolates of lymphocytic choriomeningitis virus. J. Gen. Virol. 68:2213-2218.
41. van den Broek, M.F., U. Müller, S. Huang, R.M. Zinkernagel, and M. Aguet. 1995. Immune defence in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148: 5-18.
42. Raefsky, E., L. Platanias, N. Zoumbos, and N.S. Young. 1985. Studies of interferon as a regulator of hematopoietic proliferation. J. Immunol. 135:2507-2512.
43. Quesada, J.R., J. Reuben, J.T. Manning, E.M. Hersh, and J.U. Gutterman. 1984. Alpha interferon for induction of remission in hairy-cell leukemia. N. Engl. J. Med. 310:15-18.
44. Talpaz, M., H.M. Kantarjian, K. McCredie, J.M. Trujillo, M.J. Keating, and J.U. Gutterman. 1986. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N. Engl. J. Med. 314:1065-1069.
45. Biron, C.A., H.A. Young, and M.T. Kasaian. 1990. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171:173-188.
46. Biron, C.A. 1994. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr. Opin. Immunol. 6:530-538.
47. Hansson, M., R.W. Kiessling, B. Andersson, and R.M. Welsh. 1980. Effect of interferon and interferon inducers on the NK sensitivity of normal mouse thymocytes. J. Immunol. 125: 2225-2231.
48. Hansson, M., M. Beran, B. Andersson, and R. Kiessling. 1982. Inhibition of in vitro granulopoiesis by autologous allogeneic human NK cells. J. Immunol. 129:126-132.
49. Degliantoni, G., B. Perussia, L. Mangoni, and G. Trinchieri. 1985. Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity. J. Exp. Med. 161:1152-1168.
50. Herrmann, F., R.E. Schmidt, J. Ritz, and J.D. Griffin. 1987. In vitro regulation of human hematopoiesis by natural killer cells: Analysis at a clonal level. Blood. 69:246-254.
51. Holmberg, L.A., B.A. Miller, and K.A. Ault. 1984. The effect of natural killer cells on the development of syngeneic hematopoietic progenitors. J. Immunol. 133:2933-2939.
52. Barlozzari, T., R.B. Herberman, and C.W. Reynolds. 1987. Inhibition of pluripotent hematopoietic stem cells of bone marrow by large granular lymphocytes. Proc. Natl. Acad. Sci. USA. 84:7691-7695.
53. Niemeyer, C.M., C.A. Sieff, U.R. Smith, K.A. Ault, and D.G. Nathan. 1989. Hematopoiesis in vitro coexists with natural killer lymphocytes. Blood. 74:2376-2382.
54. Cannistra, S.A., P. Groshek, and J.D. Griffin. 1988. Monocytes enhance gamma-interferon-induced inhibition of myeloid progenitor cell growth through secretion of tumor necrosis factor. Exp. Hematol. 16:865-870.
55. Stitz, L., J. Baenziger, H.P. Pircher, H. Hengartner, and R.M. Zinkernagel. 1986. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities. J. Immunol. 136:4674-4680.
56. Ehl, S., R. Nuesch, T. Tanaka, M. Myasaka, H. Hengartner, and R.M. Zinkernagel. 1996. A comparison of efficacy and specificity of three NK depleting antibodies. J. Immunol. Methods. 199:149-153.
57. Bukowski, J.F., and R.M. Welsh. 1985. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo. J. Immunol. 135:3537-3541.
58. Karre, K. 1995. Express yourself or die: peptides, MHC molecules, and NK cells. Science (Wash. DC). 267:978-979.
59. Maciejewski, J., C. Selleri, S. Anderson, and N.S. Young. 1995. Fas antigen expression on CD34+ human marrow cells is induced by IFN γ and tumor necrosis factor α and potentiates cytokine-mediated hematopoetic suppression in vitro. Blood. 11:3183-3190.
60. Takizawa, T., R. Fukuda, T. Miyawaki, K. Ohashi, and Y. Nakanishi. 1995. Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology. 209:288-296.
61. Zucker-Franklin, D., and Y. Cao. 1989. Megakaryocytes of human immunodeficiency virus-infected individuals express viral RNA. Prof. Natl. Acad. Sci. USA. 86:5595-5599.
62. Donahue, R.E., M.M. Johnson, L.I. Zon, and L.I. Groopman. 1987. Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature (Lond.). 326:200-203.
63. Levis, S.C., M.C. Saavedra, C. Ceccoli, M.R. Feuillade, D.A. Enria, J.I. Maiztegui, and R. Falcoff. 1985. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res. 5:383-389.
64. Levis, S.C., M.C. Saavedra, C. Ceccoli, E. Falcoff, M.R. Feuillade, D.A. Enria, J.I. Maiztegui, and R. Falcoff. 1984. Endogenous interferon in Argentine hemorrhagic fever. J. Infect. Dis. 149:428-433.
65. Kurane, I., B.L. Innis, and S. Nimmannitya. 1993. High levels of interferon alpha in the sera ft children with dengue virus infection. Am. J. Trop. Med. Hyg. 48:222-229.